ASCT2: a potential cancer drug target

Expert Opin Ther Targets. 2019 Jul;23(7):555-558. doi: 10.1080/14728222.2019.1627328. Epub 2019 Jun 4.

Authors

Kanu Wahi¹, Jeff Holst¹

Affiliation

¹ a Translational Cancer Metabolism Laboratory , School of Medical Sciences and Prince of Wales Clinical School, UNSW Sydney , Australia.

PMID: 31159623
DOI: 10.1080/14728222.2019.1627328

No abstract available

Keywords: ASCT2; SLC1A5; cancer; glutamine metabolism; glutamine transport.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Amino Acid Transport System ASC / antagonists & inhibitors*
Amino Acid Transport System ASC / metabolism
Animals
Antineoplastic Agents / pharmacology*
Humans
Minor Histocompatibility Antigens / metabolism
Molecular Targeted Therapy
Neoplasms / drug therapy*
Neoplasms / pathology

Substances

Amino Acid Transport System ASC
Antineoplastic Agents
Minor Histocompatibility Antigens
SLC1A5 protein, human